Studiensammlung

Zurück zur Übersicht

Filter zurücksetzen

Studiensammlung zu HIV

Andreatta, K. et al: Efficacy of Bictegravir/Emtricitabine/Tenofovir Alafenamide (B/F/TAF) Versus Dolutegravir (DTG) Based 3 Drug Regimens in Adults With HIV Who Have Suboptimal Antiretroviral Adherence

11.-15.10.2023 / ID Week

Kumar P. et al.: Week 72 Outcomes and COVID-19 Impact From the BRAAVE 2020 Study: a Randomized Switch to B/F/TAF in Black American Adults With HIV

18.-21.07.2021 / IAS

Natukunda E. et al: B/F/TAF In Virologically Suppressed Adolescents and Children: Two-year Outcomes in 6 to <18 Year Olds and Six-month Outcomes in Toddlers

16.-17.06.2021 / International Workshop on HIV & Pediatrics

Workowski, K. et al: Four-Year Outcomes of B/F/TAF in Treatment-Naïve Adults

06.-10.03.2021 / CROI

Brar I, et al.: Long-term Follow-up After a Switch to Bictegravir, Emtricitabine and Tenofovir Alafenamide from Dolutegravir, Abacavir, and Lamivudine

21.-25.10.2020 / ID Week 2020

Rockstroh J, et al.: Long-term follow-up after a switch to bictegravir, emtricitabine, tenofovir alafenamide, from a boosted protease inhibitor-based regimen

05.-08.10.2020 / HIV Drug Therapy – Glasgow